TITLE:
Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

CONDITION:
Hypercholesterolemia

INTERVENTION:
MK0653, ezetimibe

SUMMARY:

      The purpose of this 6-week study is to compare the reduction in specific levels of
      cholesterol in patients with high cholesterol.
    

DETAILED DESCRIPTION:

      The duration of treatment is 6 weeks.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  High cholesterol levels that are identified by specific laboratory values

        Exclusion Criteria:

          -  Active liver disease

          -  Any condition or situation which would interfere with participation
      
